Hypnion was acquired by Eli Lilly and Company.
Hypnion was acquired by Eli Lilly and Company.
Hypnion was acquired by Eli Lilly and Company.
Hypnion was a privately held neuroscience drug discovery company focused on sleep disorders. The acquisition/merger of Hypnion was announced by Eli Lilly and Company on March 5, 2007, and the deal was closed at the end of quarter 1 in that same year with support from stock shareholders.
March 5, 2007
Hypnion was acquired by Eli Lilly and Company.